Experimental group | Control group | ||||||
---|---|---|---|---|---|---|---|
Authors | Disorders | IL-6 (1.7–16.6 pg/ml) | IL-10 (2.6–4.9 pg/ml) | IFN-γ (1.6–17.3 pg/ml) | IL-6 (1.7–16.6 pg/ml) | IL-10 (2.6–4.9 pg/ml) | IFN-γ (1.6–17.3 pg/ml) |
Xu et al.2 | Gram-negative bacteremia vs. non-bloodstream infections | 179.3 | 22.3 | 8.3 | 52.9 | 6.3 | 7.7 |
Bacterial pneumonia vs. viral pneumonia | 884. 6 | 11.6 | 10.0 | 49.1 | 8.7 | 13.2 | |
Xu et al.3 | M. pneumoniae pneumonia vs. viral pneumonia | 334.3 | 8.0 | 29.1 | 49.1 | 8.7 | 13.2 |
Li et al.4 | KD shock syndrome vs. KD | 184.1 | 42.6 | 18.3 | 54.1 | 9.4 | 6.7 |
Guo et al.5 | MAS vs. active SJIA | 53.4 | 26.9 | 83.1 | 47.2 | 4.2 | 5.3 |
Xu et al.6 | HLH vs. healthy control | 51.1 | 623.5 | 1088.5 | 5.5 | 6.7 | 5.2 |